Machine learning for screening and predicting the risk of anti-MDA5 antibody in juvenile dermatomyositis children
Authors:
Open Access
- 10 January 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 940802
Abstract
Objective: The anti-MDA5 (anti-melanoma differentiation associated gene 5) antibody is often associated with a poor prognosis in juvenile dermatomyositis (JDM) patients. In many developing countries, there is limited ability to access myositis- specific antibodies due to financial and technological issues, especially in remote regions. This study was performed to develop a prediction model for screening anti-MDA5 antibodies in JDM patients with commonly available clinical findings.Methods: A cross-sectional study was undertaken with 152 patients enrolled from the inpatient wards of Beijing Children’s Hospital between June 2018 and September 2021. Stepwise logistic regression, least absolute shrinkage and selection operator (LASSO) regression, and the random forest (RF) method were used to fit the model. Model discrimination, calibration, and decision curve analysis were performed for validation.Results: The final prediction model included eight clinical variables (gender, fever, alopecia, periungual telangiectasia, digital ulcer, interstitial lung disease, arthritis/arthralgia, and Gottron sign) and four auxiliary results (WBC, CK, CKMB, and ALB). An anti-MDA5 antibody risk probability–predictive nomogram was established with an AUC of 0.975 predicted by the random forest algorithm. The model was internally validated by Harrell’s concordance index (0.904), the Brier score (0.052), and a 500 bootstrapped satisfactory calibration curve. According to the net benefit and predicted probability thresholds of decision curve analysis, the established model showed a significantly higher net benefit than the traditional logistic regression model.Conclusion: We developed a prediction model using routine clinical assessments to screen for JDM patients likely to be anti-MDA5 positive. This new tool may effectively predict the detection of anti-MDA5 in these patients using a non-invasive and efficient way.Keywords
This publication has 27 references indexed in Scilit:
- Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositisRheumatology, 2012
- A Comparison of Logistic Regression Analysis and an Artificial Neural Network Using the BI-RADS Lexicon for Ultrasonography in Conjunction with Introbserver VariabilityJournal of Digital Imaging, 2012
- The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective studyJournal of the American Academy of Dermatology, 2011
- Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositisRheumatology, 2010
- RNA helicase encoded by melanoma differentiation–associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung diseaseArthritis & Rheumatism, 2009
- Long-term outcomes in juvenile dermatomyositis: How did we get here and where are we going?Current Rheumatology Reports, 2005
- Regularization and Variable Selection Via the Elastic NetJournal of the Royal Statistical Society Series B: Statistical Methodology, 2005
- US incidence of juvenile dermatomyositis, 1995–1998: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases RegistryArthritis Care & Research, 2003
- THE INCIDENCE OF JUVENILE DERMATOMYOSITIS: RESULTS FROM A NATION-WIDE STUDYRheumatology, 1995
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975